TVARDI THERAPEUTICS, INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
TVARDI THERAPEUTICS, INC. (TVRD) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 50.11 million shares for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-08.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2021-11-08
- TVARDI THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 50.11M shares, a 6.89% increase year-over-year.
- TVARDI THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 50.06M shares, a 6.97% increase year-over-year.
- TVARDI THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 49.92M shares, a 6.83% increase year-over-year.
- TVARDI THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-09-30 was 46.89M shares, a 5.32% increase year-over-year.
- TVARDI THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 42.67M shares, a 18.88% increase from fiscal 2018.
- TVARDI THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 35.89M shares, a 15.03% increase from fiscal 2017.
- TVARDI THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2017 was 31.20M shares, a 14.38% increase from fiscal 2016.
- TVARDI THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2016 was 27.28M shares, a 10.80% increase from fiscal 2015.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2021-09-30 | 50.11M shares 10-Q · filed 2021-11-08 | 50.09M shares derived: average of 2 quarters · filed 2021-11-08 | 50.03M shares 10-Q · filed 2021-11-08 | |
| 2021-06-30 | 50.06M shares 10-Q · filed 2021-08-09 | 49.99M shares 10-Q · filed 2021-08-09 | ||
| 2021-03-31 | 49.92M shares 10-Q · filed 2021-05-10 | |||
| 2020-09-30 | 46.89M shares 10-Q · filed 2021-11-08 | 46.84M shares derived: average of 2 quarters · filed 2021-11-08 | 46.80M shares 10-Q · filed 2021-11-08 | 46.79M shares derived: average of 4 quarters · filed 2021-11-08 |
| 2020-06-30 | 46.80M shares 10-Q · filed 2021-08-09 | 46.76M shares 10-Q · filed 2021-08-09 | 46.75M shares derived: average of 3 quarters · filed 2021-08-09 | 46.19M shares derived: average of 4 quarters · filed 2021-08-09 |
| 2020-03-31 | 46.72M shares 10-Q · filed 2021-05-10 | 46.73M shares derived: average of 2 quarters · filed 2021-05-10 | 45.99M shares derived: average of 3 quarters · filed 2021-05-10 | 44.45M shares derived: average of 4 quarters · filed 2021-05-10 |
| 2019-12-31 | 46.74M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | 45.63M shares derived: average of 2 quarters · filed 2020-11-09 | 43.69M shares derived: average of 3 quarters · filed 2020-11-09 | 42.67M shares 10-K · filed 2020-02-27 |
| 2019-09-30 | 44.52M shares 10-Q · filed 2020-11-09 | 42.17M shares derived: average of 2 quarters · filed 2020-11-09 | 41.31M shares 10-Q · filed 2020-11-09 | 40.84M shares derived: average of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | 39.82M shares 10-Q · filed 2020-08-10 | 39.69M shares 10-Q · filed 2020-08-10 | 39.62M shares derived: average of 3 quarters · filed 2020-08-10 | 39.22M shares derived: average of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | 39.55M shares 10-Q · filed 2020-05-11 | 39.52M shares derived: average of 2 quarters · filed 2020-05-11 | 39.02M shares derived: average of 3 quarters · filed 2020-05-11 | 37.60M shares derived: average of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | 39.48M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | 38.76M shares derived: average of 2 quarters · filed 2020-02-27 | 36.94M shares derived: average of 3 quarters · filed 2020-02-27 | 35.89M shares 10-K · filed 2020-02-27 |
| 2018-09-30 | 38.03M shares 10-Q · filed 2019-11-05 | 35.68M shares derived: average of 2 quarters · filed 2019-11-05 | 34.70M shares 10-Q · filed 2019-11-05 | 34.16M shares derived: average of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | 33.32M shares 10-Q · filed 2019-08-07 | 33.00M shares 10-Q · filed 2019-08-07 | 32.87M shares derived: average of 3 quarters · filed 2020-02-27 | 32.80M shares derived: average of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | 32.68M shares 10-Q · filed 2019-05-07 | 32.65M shares derived: average of 2 quarters · filed 2020-02-27 | 32.63M shares derived: average of 3 quarters · filed 2020-02-27 | 32.53M shares derived: average of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | 32.62M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | 32.61M shares derived: average of 2 quarters · filed 2020-02-27 | 32.48M shares derived: average of 3 quarters · filed 2020-02-27 | 31.20M shares 10-K · filed 2020-02-27 |
| 2017-09-30 | 32.59M shares 10-Q · filed 2018-11-06 | 32.42M shares derived: average of 2 quarters · filed 2018-11-06 | 30.73M shares 10-Q · filed 2018-11-06 | 29.86M shares derived: average of 4 quarters · filed 2019-03-12 |
| 2017-06-30 | 32.24M shares 10-Q · filed 2018-08-07 | 29.78M shares 10-Q · filed 2018-08-07 | 28.94M shares derived: average of 3 quarters · filed 2019-03-12 | 28.53M shares derived: average of 4 quarters · filed 2019-03-12 |
| 2017-03-31 | 27.30M shares 10-Q · filed 2018-05-09 | 27.30M shares derived: average of 2 quarters · filed 2019-03-12 | 27.29M shares derived: average of 3 quarters · filed 2019-03-12 | 27.29M shares derived: average of 4 quarters · filed 2019-03-12 |
| 2016-12-31 | 27.29M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | 27.29M shares derived: average of 2 quarters · filed 2019-03-12 | 27.29M shares derived: average of 3 quarters · filed 2019-03-12 | 27.28M shares 10-K · filed 2019-03-12 |
| 2016-09-30 | 27.28M shares 10-Q · filed 2017-11-02 | 27.28M shares derived: average of 2 quarters · filed 2017-11-02 | 27.28M shares 10-Q · filed 2017-11-02 | 27.27M shares derived: average of 4 quarters · filed 2018-03-15 |
| 2016-06-30 | 27.28M shares 10-Q · filed 2017-08-03 | 27.27M shares 10-Q · filed 2017-08-03 | 27.27M shares derived: average of 3 quarters · filed 2018-03-15 | 26.84M shares derived: average of 4 quarters · filed 2018-03-15 |
| 2016-03-31 | 27.26M shares 10-Q · filed 2017-05-04 | 27.26M shares derived: average of 2 quarters · filed 2018-03-15 | 26.69M shares derived: average of 3 quarters · filed 2018-03-15 | 25.73M shares derived: average of 4 quarters · filed 2018-03-15 |
| 2015-12-31 | 27.27M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | 26.41M shares derived: average of 2 quarters · filed 2018-03-15 | 25.21M shares derived: average of 3 quarters · filed 2018-03-15 | 24.62M shares 10-K · filed 2018-03-15 |
| 2015-09-30 | 25.55M shares 10-Q · filed 2016-11-04 | 24.19M shares derived: average of 2 quarters · filed 2016-11-04 | 23.74M shares 10-Q · filed 2016-11-04 | 23.50M shares derived: average of 4 quarters · filed 2017-03-10 |
| 2015-06-30 | 22.83M shares 10-Q · filed 2016-08-04 | 22.82M shares 10-Q · filed 2016-08-04 | 22.82M shares derived: average of 3 quarters · filed 2017-03-10 | 22.79M shares derived: average of 4 quarters · filed 2017-03-10 |
| 2015-03-31 | 22.81M shares 10-Q · filed 2016-05-05 | 22.81M shares derived: average of 2 quarters · filed 2017-03-10 | 22.78M shares derived: average of 3 quarters · filed 2017-03-10 | 22.74M shares derived: average of 4 quarters · filed 2017-03-10 |
| 2014-12-31 | 22.81M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | 22.76M shares derived: average of 2 quarters · filed 2017-03-10 | 22.71M shares derived: average of 3 quarters · filed 2017-03-10 | 20.97M shares 10-K · filed 2017-03-10 |
| 2014-09-30 | 22.71M shares 10-Q · filed 2015-11-09 | 22.66M shares derived: average of 2 quarters · filed 2015-11-09 | 20.35M shares 10-Q · filed 2015-11-09 | 16.32M shares derived: average of 4 quarters · filed 2016-03-11 |
| 2014-06-30 | 22.61M shares 10-Q · filed 2015-08-10 | 19.15M shares 10-Q · filed 2015-08-10 | 14.18M shares derived: average of 3 quarters · filed 2016-03-11 | 11.71M shares derived: average of 4 quarters · filed 2016-03-11 |
| 2014-03-31 | 15.65M shares 10-Q · filed 2015-05-12 | 9.97M shares derived: average of 2 quarters · filed 2016-03-11 | 8.08M shares derived: average of 3 quarters · filed 2016-03-11 | |
| 2013-12-31 | 4.29M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | 4.29M shares derived: average of 2 quarters · filed 2016-03-11 | 4.13M shares 10-K · filed 2016-03-11 | |
| 2013-09-30 | 4.29M shares 10-Q · filed 2014-11-10 | 4.08M shares 10-Q · filed 2014-11-10 | ||
| 2013-03-31 | 3.66M shares 10-Q · filed 2014-05-12 | |||
| 2012-12-31 | 3.30M shares 10-K · filed 2015-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |